AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Sees Large Growth in Short Interest

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the recipient of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 873,918 shares, an increase of 90.8% from the August 15th total of 458,107 shares. Approximately 3.5% of the shares of the stock are short sold. Based on an average trading volume of 476,023 shares, the short-interest ratio is presently 1.8 days.

AGF U.S. Market Neutral Anti-Beta Fund Price Performance

Shares of NYSEARCA:BTAL traded down $0.10 during trading on Wednesday, hitting $12.49. 497,827 shares of the company’s stock were exchanged, compared to its average volume of 796,383. The business’s 50-day simple moving average is $12.07 and its 200 day simple moving average is $12.43. The company has a market cap of $314.75 million, a price-to-earnings ratio of 17.67 and a beta of -0.64. AGF U.S. Market Neutral Anti-Beta Fund has a 52-week low of $10.86 and a 52-week high of $16.14.

Institutional Investors Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Institutional investors have recently added to or reduced their stakes in the stock. Crescent Grove Advisors LLC bought a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund during the first quarter valued at approximately $6,614,000. PMV Capital Advisers LLC grew its stake in AGF U.S. Market Neutral Anti-Beta Fund by 14.0% during the first quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock valued at $3,443,000 after acquiring an additional 30,234 shares in the last quarter. Worth Asset Management LLC grew its stake in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock valued at $425,000 after acquiring an additional 5,190 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% in the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock valued at $380,000 after acquiring an additional 10,146 shares during the last quarter. Finally, CoreCap Advisors LLC bought a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter valued at $36,000.

About AGF U.S. Market Neutral Anti-Beta Fund

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.